Clinical Trial Intelligence

Your Competitive Landscape Shouldn't Take Three Weeks to Build

Kognitic Core structures global oncology trial data into a single, continuously updated view which enables your team to work from a live competitive position, not a reconciliation backlog.

AURORA-Breast03 Prediction

Confidence 75

Sponsor PCD

Sep 2026

AI Predicted PCD

Oct 2026

Confidence Score

75%

© 2026 Kognitic · Clinical Trial Timeline · Decision Grade Intelligence

Partners Powered by Kognitic

Merck
Daiichi Sankyo
Bayer
Bristol Myers Squibb
EMD Serono
Sanofi
Johnson & Johnson
SystImmune
PharmaEssentia
Merck
Daiichi Sankyo
Bayer
Bristol Myers Squibb
EMD Serono
Sanofi
Johnson & Johnson
SystImmune
PharmaEssentia

Clinical Trial Intelligence

CORE

Every trial on one timeline

Visualize enrollment windows, data readouts, and primary endpoint milestones across phases and quarters. No more reconciling registries against internal trackers. One structured timeline, grounded in published data, that your team references before every portfolio conversation.

Every trial on one timeline — Kognitic Core

CORE

Full trial architecture in one view

Eligibility criteria, biomarker strategy, randomization arms, primary and secondary endpoints. Every trial was normalized into a comparable schema. The complexity stays. The manual effort disappears.

Full trial architecture in one view — Kognitic Core

CORE

Density and white space at a glance

See where the development activity is concentrated and where the gaps remain. Indication level heatmaps organized by phase, modality, and mechanism of action. The visual that replaces weeks of competitive mapping.

Density and white space at a glance — Kognitic Core
PRECLINICAL PHASE 1 PHASE 2 PHASE 3 APPROVED ARV-TRACTr Nexagen Therapeutics Neuvaxil Harmon Pharma VX-1180 ADC Halus Therapeutics AMR-716 Noveral Bio MKR-311 LaborPro Steinbrook SGR-1003 Salaris Novartis PAX-828 Govitecan Orin Labs JC3M801 Irinotecan Bricton / Apex Pharma DRX-502 Prolos Therapeutics CNX-036C CellNova Inc ETR-209 Conjugate Bellarion Oncology 2NT-440 Gran Labs BRX-1107 Mendell Biotech NRX-501 Lanovar Oncology PLX-8845 Oculus Med KGN-5 Orbis Bio CPT-3022 Clavender Biomed MVX-317 Harnwell Medical AGX-104 Vela Biosciences FLT-992 Tradisome Inc BLT-558 ADC Quintara Therapeutics TRP-220 Solaris Oncology ZPN-001 Arca Genomics RXV-190 Delos Biopharma CLX-874 Fenwick BioLabs

See Where Your Assets Sits Act Before the Window Closes

In crowded therapeutic areas, the difference between best-in-class and second-to-market comes down to timing and positioning. Kognitic's Core structures the clinical landscape so your team can assess both.

Every trial arm, patient cohort, and efficacy endpoint is normalized into a comparable standard. Your competitive view is not a spreadsheet assembled over three weeks. It is a live, defensible position you can take to a portfolio review.

The Same Week. Two Different Outcomes.

Before Kognitic Core

Three analysts. Five data sources. A reconciliation cycle that starts after the congress ends and finishes when the window has already moved. Static deliverables that are outdated before the PDF is attached.

After Kognitic Core

One structured view. Updated continuously. Every team was aligned on the same normalized evidence from day one. The reconciliation step is gone. The decision happens on schedule.

Kognitic Core platform dashboard
core.kognitic.com/home

Built for the Decisions That Define Your Quarter

BD&L / ASSET EVALUATION

Is this asset best-in-class, or just differentiated enough?

Core shows the competitive context: how the asset's clinical profile compares to every other program in the indication, with normalized efficacy data and realistic visibility into timelines. Your BD team walks into the diligence meeting with a structured position.

COMMERCIAL STRATEGY

Where is the white space, and how long before a competitor fills it?

Core maps development density by phase, modality, and mechanism of action. Surface the gaps before they close and build the case your leadership team can defend.

MEDICAL AFFAIRS

What does the evidence landscape actually look like, normalized?

Core eliminates weeks of manual benchmarking. Ground your analyses in structured, comparable trial data and bring a defensible evidence view to your leadership review.

See Your Landscape
Through Core

This is not a product tour. Our team will walk you through a live analysis of your therapeutic area, structured in Core, using your competitive context. One hour. Your landscape. Structured.